Spondyloarthropathies

Top Story

Direct-to-consumer genetic testing not ready for prime time in rheumatology

Direct-to-consumer genetic testing not ready for prime time in rheumatology
January 18, 2019
In the Journals

Ankylosing spondylitis significantly reduces health-related quality of life

January 16, 2019
Patients with ankylosing spondylitis experience significantly reduced health-related quality of life, defined by the Medical Outcome Survey Short Form-36, compared with…
Meeting News

Phase 3 data support etanercept monotherapy for PsA

December 13, 2018
CHICAGO — Phase 3 data from the SEAM-PsA study presented at the ACR/ARHP 2018 Annual Meeting showed that etanercept alone or in combination with methotrexate was…
Meeting News

AS linked to increased risk for certain cancer types

December 12, 2018
CHICAGO — Patients with ankylosing spondylitis had an increased risk for melanoma, hematological malignancies, kidney and thyroid cancer but a reduced risk for…
More Headlines »
CME

Updates in PsA and SpA: Optimizing Care Among the Latest Advances

This activity is supported by an educational grant from Lilly.

Chronic inflammatory diseases, such as psoriatic arthritis (PsA) and ankylosing spondylitis (AS), represent a group of…
More »
Video
Meeting News

VIDEO: Rheumatologists miss patients with axial spondyloarthritis

March 26, 2017
More »
CME

Highlights of the Rheumatology Summit: A Master Class in RA, PsA, and SpA

This activity is supported by independent educational grants from AbbVie; Celgene Corporation; Lilly USA, LLC; Merck & Co., Inc.; and Pfizer, Inc.

This CME-certified monograph is specifically designed for health care professionals to advance their knowledge…
More »